Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes. Clinics, [S. l.], v. 76, p. e2587, 2022. DOI: 10.6061/clinics/2021/e2587. Disponível em: https://revistas.usp.br/clinics/article/view/191921.. Acesso em: 1 jun. 2024.